Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - Net
Ratios

Phathom Pharmaceuticals (PHAT) Long-Term Debt Issuances (2023 - 2024)

Phathom Pharmaceuticals (PHAT) has disclosed Long-Term Debt Issuances for 2 consecutive years, with $24.8 million as the latest value for Q4 2024.

  • Quarterly Long-Term Debt Issuances fell 37.05% to $24.8 million in Q4 2024 from the year-ago period, while the trailing twelve-month figure was $24.8 million through Sep 2025, down 66.54% year-over-year, with the annual reading at $59.4 million for FY2024, 51.08% up from the prior year.
  • Long-Term Debt Issuances for Q4 2024 was $24.8 million at Phathom Pharmaceuticals, roughly flat from $24.8 million in the prior quarter.
  • The five-year high for Long-Term Debt Issuances was $39.3 million in Q4 2023, with the low at $9.9 million in Q1 2024.